The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
The Oral GLP-1 Tracker: Foundayo still lagging Wegovy pill in week 3, but commercial coverage is coming Fierce Pharma
The Oral GLP-1 Tracker: Foundayo still lagging Wegovy pill in week 3, but commercial coverage is coming Fierce Pharma